fig2

Targeting T regulatory (T<sub>reg</sub>) cells in immunotherapy-resistant cancers

Figure 2. Characterization of Treg cells and subsets: CD4+ T cells egress from the thymus and differentiate in blood and tumor tissue. Depending on the degree of CD45RA and FOXP3 expression, CD4+ are defined as nTreg cells. CD4+ or nTreg cells egress into the periphery, where either cell population is subsequently altered and selected for different types of Treg cells. Based on the “selection model”, CD4+ naïve cells are selected to transition into iTreg cells, differing in their functional status as “Tr1 cells” or Th3 cells. FOXP3: Forkhead box protein P3; nTreg: natural T regulatory cells; iTreg: induced Treg cells; Tr1 cells: type 1 Treg cells; Th3 cells: T helper 3 cells.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/